Pacientes Colombia cuestiona designación de Drogas La Rebaja como gestor farmacéutico del sistema público

TL;DR

Pacientes Colombia criticizes the designation of Drogas La Rebaja as the pharmaceutical manager for the public drug system.
The organization claims the decision lacks legal, technical, and sanitary justifications.
Drogas La Rebaja reportedly lacks specific authorizations from Invima and the Ministry of Health required for this role.
Pacientes Colombia distinguishes between commercial drug sales and public pharmaceutical management, which requires institutional capabilities and certifications.
The group argues that an administrative intervention on Drogas La Rebaja does not automatically grant it new health functions or authorizations.
Key requirements for a pharmaceutical manager include a certified cold chain, interoperable information systems, active pharmacovigilance, and financial capacity for mass public purchases.
Pacientes Colombia warns that announcing non-existent capabilities creates false expectations and risks the continuity of therapeutic treatments.
The organization plans to escalate these concerns to the Ministry of Health and Invima.

Continuar leyendo el artículo original